🧬 Aging Wiki
Search
Search
Dark mode
Light mode
Reader mode
Explorer
gap/unverifiable-from-main-text
1 item with this tag.
Aug 18, 2026
Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study
gap/long-term-unknown
gap/unverifiable-from-main-text
gap/needs-replication
gap/needs-human-replication
stub